Invivyd (IVVD) Other Working Capital Changes (2021 - 2025)
Invivyd posted quarterly Other Working Capital Changes of -$11.9 million for Q4 2025, down 187.1% year-on-year from $13.6 million in Q4 2024, and down 416.09% on a QoQ basis from $3.8 million in Q3 2025.
Invivyd (IVVD) has 5 years of Other Working Capital Changes data on file, last reported at -$11.9 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 187.1% year-over-year to -$11.9 million; the trailing twelve-month figure through Dec 2025 stood at -$12.9 million (down 677.15% YoY), and the FY2025 full-year result was -$12.9 million, down 677.15% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$11.9 million, down from $3.8 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $22.9 million in Q4 2021 and bottomed at -$20.4 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$406000.0 (2024), against an average of -$907600.0.
- The widest annual swing landed in 2023, when Other Working Capital Changes plunged 657.21%; it then surged 3512.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $22.9 million in 2021, then sank by 188.92% to -$20.4 million in 2022, then surged by 98.04% to -$400000.0 in 2023, then soared by 3512.0% to $13.6 million in 2024, then sank by 187.1% to -$11.9 million in 2025.
- The last three Other Working Capital Changes figures came in at -$11.9 million (Q4 2025), $3.8 million (Q3 2025), and -$4.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.89 Mn |
| Dec 31, 2025 | -11.89 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | -4.39 Mn |
| Jun 30, 2025 | -4.39 Mn |
| Mar 31, 2025 | -410,000.00 |
| Mar 31, 2025 | -410,000.00 |
| Dec 31, 2024 | 13.65 Mn |
| Dec 31, 2024 | 13.65 Mn |
| Sep 30, 2024 | -7.88 Mn |
| Sep 30, 2024 | -7.88 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Mar 31, 2024 | -406,000.00 |
| Mar 31, 2024 | -406,000.00 |
| Dec 31, 2023 | -400,000.00 |
| Dec 31, 2023 | -400,000.00 |
| Sep 30, 2023 | -1.16 Mn |
| Sep 30, 2023 | -1.16 Mn |
| Dec 31, 2022 | -20.36 Mn |
| Dec 31, 2022 | -20.36 Mn |
| Sep 30, 2022 | 208,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | -145,000.00 |
| Jun 30, 2022 | -145,000.00 |
| Mar 31, 2022 | -69,000.00 |
| Mar 31, 2022 | -69,000.00 |
| Dec 31, 2021 | 22.90 Mn |
| Dec 31, 2021 | 22.90 Mn |